Skip to main content

Digital Trends may earn a commission when you buy through links on our site. Why trust us?

Musk doubles down on promises for Optimus humanoid robots

The Tesla Suit Optimus with a black background.
Tesla

Tesla is once again delaying the production of its Optimus humanoid robot, CEO Elon Musk announced on X (formerly Twitter) Monday.

During April’s annual investor meeting, Musk told shareholders that Optimus would move into limited production in 2025 and predicted that “thousands” of the robots would be working in Tesla factories by the end of the year. He also hypothesized that sales of the robot, which is expected to retail for between $20,000 and $30,000, could add as much as $20 trillion to the company’s market capitalization.

“Tesla will have genuinely useful humanoid robots in low production for Tesla internal use next year and, hopefully, high production for other companies in 2026,” he amended Monday. Musk did not explain what he considers “genuinely useful” functionality.

Two Optimus robots reportedly work in one of Tesla’s factories, though the company has not revealed what their actual duties on the floor are. A recent promotional video from the company showed a second-generation Optimus folding shirts.

Optimus folds a shirt pic.twitter.com/3F5o3jVLq1

— Elon Musk (@elonmusk) January 15, 2024

Of course, this isn’t the first time that Musk has over-promised his investors on delivering product. In 2019, he claimed that Tesla’s Full Self-Driving autonomous vehicle assist would enable the company to roll out a fleet of “robotaxis” by 2020. Those have yet to arrive, though Musk posted on X last week that the company is taking additional time to unveil its autonomous cabs in order to incorporate “an important design change” to the front of the vehicle.

What’s more, the Cybertruck was initially supposed to hit the street in 2021, but multiple delays pushed back its release to November 2023. And even after its debut, the company has repeatedly paused and rescheduled delivery of the long-awaited electric SUV to customers. And who can forget that the first “Optimus” ever revealed on stage was actually just a guy in a lycra bodysuit?

“A sentient humanoid robot by 2025? I mean come on, they tried to launch this product with a dancer inside of a robot suit,” Roth MKM analyst Craig Irwin quipped on Yahoo Finance Monday. “It’s gonna be hard for them to catch up to Boston Dynamics. What they’ve shown us is really state of the art for 2014.”

Andrew Tarantola
Andrew has spent more than a decade reporting on emerging technologies ranging from robotics and machine learning to space…
Elon Musk’s Neuralink now recruiting for first human trials
Everything you need to know about Neuralink

Elon Musk’s Neuralink company has announced that it’s now accepting applications from human subjects willing to have its experimental N1 computer interface implanted in their brain.

Neuralink’s first in-human study, called PRIME (Precise Robotically Implanted Brain-Computer Interface), is encouraging interest from those with quadriplegia due to cervical spinal cord injury or amyotrophic lateral sclerosis (ALS). They should also be at least 22 years old and have a consistent and reliable caregiver.

Read more
Elon Musk’s new AI company aims to ‘understand the universe’
A digital image of Elon Musk in front of a stylized background with the Twitter logo repeating.

Elon Musk has just formed a new company that will seek to “understand the true nature of the universe.” No biggie, then.

Announced on Wednesday, the company, xAI, already has among its ranks artificial intelligence (AI) experts formerly of firms such as DeepMind, OpenAI, Google Research, Microsoft Research, and Tesla.

Read more
Elon Musk’s Neuralink gets FDA nod to test brain implant in humans
Elon Musk stands in front of the Neuralink logo.

Seven years after its launch, Elon Musk’s Neuralink company has finally secured approval from the U.S. Food and Drug Administration (FDA) to implant a computer inside a human brain.

“We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study,” Neuralink tweeted on Thursday. “This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people.”

Read more